- Home
- TISI vs VYNE Comparison
TISI vs VYNE Comparison
Compare TISI & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TISI
- VYNE
- Stock Information
- Founded
- TISI 1973
- VYNE 2003
- Country
- TISI United States
- VYNE United States
- Employees
- TISI N/A
- VYNE N/A
- Industry
- TISI Other Consumer Services
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- TISI Consumer Discretionary
- VYNE Health Care
- Exchange
- TISI Nasdaq
- VYNE Nasdaq
- Market Cap
- TISI 92.9M
- VYNE 16.0M
- IPO Year
- TISI N/A
- VYNE 2018
- Fundamental
- Price
- TISI $18.69
- VYNE $1.77
- Analyst Decision
- TISI
- VYNE Strong Buy
- Analyst Count
- TISI 0
- VYNE 2
- Target Price
- TISI N/A
- VYNE $6.25
- AVG Volume (30 Days)
- TISI 18.6K
- VYNE 1.1M
- Earning Date
- TISI 08-07-2025
- VYNE 08-13-2025
- Dividend Yield
- TISI N/A
- VYNE N/A
- EPS Growth
- TISI N/A
- VYNE N/A
- EPS
- TISI N/A
- VYNE N/A
- Revenue
- TISI $851,327,000.00
- VYNE $605,000.00
- Revenue This Year
- TISI N/A
- VYNE $42.51
- Revenue Next Year
- TISI N/A
- VYNE N/A
- P/E Ratio
- TISI N/A
- VYNE N/A
- Revenue Growth
- TISI N/A
- VYNE 43.03
- 52 Week Low
- TISI $7.65
- VYNE $0.85
- 52 Week High
- TISI $26.77
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- TISI 53.25
- VYNE 73.11
- Support Level
- TISI $17.66
- VYNE $0.85
- Resistance Level
- TISI $21.33
- VYNE $1.75
- Average True Range (ATR)
- TISI 1.08
- VYNE 0.18
- MACD
- TISI -0.03
- VYNE 0.11
- Stochastic Oscillator
- TISI 57.55
- VYNE 82.88
About TISI Team Inc.
Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.